Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHB4 | P54760 | 6/20 | 1.00 |
| ▸ | BTK | Q06187 | 4/20 | 0.51 |
| ▸ | FYN | P06241 | 5/20 | 0.48 |
| ▸ | LCK | P06239 | 3/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | HCK | P08631 | 2/20 | 0.46 |
| ▸ | BRAF | P15056 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4471359 | 0.87 | EPHB4 (1.00) | EPHB4BTKFYNLCKKDR | |
| SCHEMBL4472168 | 0.84 | EPHB4 (0.72) | EPHB4BTKFYNKDR | |
| SCHEMBL4467196 | 0.84 | EPHB4 (1.00) | EPHB4BTKFYNKDR | |
| SCHEMBL4469106 | 0.83 | EPHB4 (0.76) | EPHB4FYNKDRBRAF | |
| SCHEMBL4473618 | 0.82 | EPHB4 (1.00) | EPHB4FYNKDR | |
| SCHEMBL4489673 | 0.81 | EPHB4 (0.68) | EPHB4BTKFYNLCKKDR | |
| SCHEMBL4471724 | 0.81 | EPHB4 (0.72) | EPHB4FYNKDRBRAF | |
| SCHEMBL4461250 | 0.81 | EPHB4 (0.70) | EPHB4BTKFYNLCKKDR | |
| SCHEMBL4479941 | 0.80 | EPHB4 (0.76) | EPHB4BTKFYNKDR | |
| SCHEMBL4464914 | 0.79 | EPHB4 (0.69) | EPHB4FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592352-B2 | Substituted thieno and furo-pyridines | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | claimed |
| US-20080182868-A1 | Novel chemical compounds | SMITHKLINE BEECHAM CORPORATION | 2008-07-31 | — | — | US | claimed |
| JP-2006528685-A | — | — | 2006-12-21 | — | — | JP | claimed |
| EP-1620094-A2 | NOVEL CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-02-01 | — | — | EP | claimed |
| WO-2004100947-A2 | NOVEL CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-11-25 | — | — | WO | claimed |
| US-7592352-B2 | Substituted thieno and furo-pyridines | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592352-B2 | Substituted thieno and furo-pyridines | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-20080182868-A1 | Novel chemical compounds | SMITHKLINE BEECHAM CORPORATION | 2008-07-31 | — | — | US | disclosed |
| US-20080182868-A1 | Novel chemical compounds | SMITHKLINE BEECHAM CORPORATION | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182868-A1 | Novel chemical compounds | HRAS, VHL, TP53 | EPHB4 2484/4885BTK 464/4885FYN 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.